Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-029518

Chief Medical Officer acquired 104,725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Huertas Pedro Chief Medical Officer 2018-05-11 Grant or award +104,725 104,725 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Huertas Pedro Chief Medical Officer 2018-05-10 Grant or award · Employee Stock Option (Right to Buy) +104,725 104,725 D: show line 2 in the form
Loading xslF345X03/doc4.xml…